Development of a Segmental Bioelectrical Impedance Spectroscopy Device for Body Composition Measurement
NCT ID: NCT04006899
Last Updated: 2019-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5 participants
OBSERVATIONAL
2018-06-20
2019-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Bioimpedance Body Composition Device Measurements
NCT01888068
Validity and Reliability of Commercially Available Bioelectrical Impedance Analysis Devices
NCT05026697
Comparison Study for Bioelectrical Impedance Device to Measure Human Body Composition
NCT00956917
InBody Validation Study
NCT02635958
Tanita BIA System Validation
NCT02118675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The reference devices will be used to measure segments as well, and the raw measurements will be compared. The Multiscan 5000 provides segmental body composition for the arm or leg, but requires measuring it separately. The SFB7 is designed only for measuring the whole body, but the raw impedance measurement data from the SFB7 can be used for comparison, as the impedance magnitudes of individual segments will be within its measurement range. The Seca 514 doesn't directly measure segments, but it can provide segmental data by measuring from hand to foot, then from hand to hand, and finally from foot to foot. It then uses these measurements, and assumptions about the subject to provide segmental composition data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
subj 1
Three commercially available BIA devices vs SBIS device
Bioelectrical Impedance Monitor
Subjects had been under the test of three commercially available devices and the device that the investigators had developed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bioelectrical Impedance Monitor
Subjects had been under the test of three commercially available devices and the device that the investigators had developed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jun Choi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jun Choi
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
junghun choi, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Georgia Southern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Georgia Southern University
Statesboro, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GSU001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.